Chuan-Sheng Niu

Title: Chuan-Sheng Niu: Innovator in Ribonucleotide Reductase Inhibitors

Introduction

Chuan-Sheng Niu is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrug forms of ribonucleotide reductase inhibitors. His work focuses on enhancing the efficacy and bioavailability of these compounds.

Latest Patents

Chuan-Sheng Niu holds a patent for "Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP." This invention relates to novel prodrug forms of ribonucleoside diphosphate reductase inhibitors, specifically 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde thiosemicarbazone (3-AMP). These compounds exhibit increased water solubility, bioavailability, and resistance to in vivo acetylation of their amino functions.

Career Highlights

Chuan-Sheng Niu has been associated with Vion Pharmaceuticals, Inc., where he has contributed to innovative research and development in the pharmaceutical industry. His work has the potential to impact the treatment of various diseases by improving the effectiveness of ribonucleotide reductase inhibitors.

Collaborations

Chuan-Sheng Niu has collaborated with notable colleagues, including Jun Li and Xiuyan Li. Their combined expertise has contributed to advancements in the field of drug development.

Conclusion

Chuan-Sheng Niu's innovative work in the development of prodrug forms of ribonucleotide reductase inhibitors showcases his commitment to enhancing pharmaceutical efficacy. His contributions are significant in the ongoing quest for improved therapeutic options.